Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.
A link to the prescribing information can be found in the header.
Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) is indicated for symptomatic treatment of focal spasticity of:
- Upper limbs in adults
- Lower limbs in adults affecting the ankle joint
Please click here to see the full therapeutic indications.
CLIMB Online
Adult Spasticity
Dysport® Dose Map for Adult Focal Spasticity
A downloadable reference guide to the dosing of Dysport® for the treatment of adult focal spasticity
DYS-UK-008777
Dysport® Reconstitution Guide
7 minutes
How to prepare, reconstitute and store Dysport®
DYS-UK-008719
Management of Spasticity in Adults – eLearning Module
20 minutes
An overview of the management of adult spasticity with a focus on the principles of spasticity and upper motor neurone syndrome pathophysiology, the harmful effects of adult spasticity, and management and treatment options
DYS-UK-008754
Patient Considerations & Goal Setting – eLearning Module
20 minutes
Patient considerations in spasticity management and an introduction to goal setting with a focus on the patient’s perspective and Goal Attainment Scaling (GAS)
DYS-UK-008755
Diagnosis and assessment of spasticity in adults – eLearning Module
20 minutes
An introduction to spasticity diagnosis and assessment with a focus on functional anatomy and impairment in spasticity, range of motion and mobility
DYS-UK-008756
Management of spasticity with BoNT-A – eLearning Module
20 minutes
An introduction to botulinum toxin with an overview of the mechanism of action of botulinum toxin type A, patient selection and Dysport® for the treatment of adult spasticity
DYS-UK-008757
Dysport® Clinical Trial Data – eLearning Module
20 minutes
An overview of the Dysport® clinical trial programme for spasticity in the upper and lower limb and real-life studies for botulinum toxin type A for spasticity upper and lower limb.
DYS-UK-008760
Navigating the Switch between BoNT-As: The North Staffordshire Rehabilitation Centre Experience
10 minutes
Dr Clive Bezzina shares his personal experience switching between BoNT-As within his spasticity service, and the outcomes seen for both the patients and the service.
DYS-UK-008724
Tackling the capacity challenge in your clinics with Dysport®
12 minutes
Dr Michelle Kirkland discusses Dysport® time to retreatment in clinical trials and how moving to Dysport® may allow adult patients with focal spasticity to avoid unnecessary appointments and contribute to increasing clinic capacity.
DYS-UK-008739
Finding flexibility within Botulinum Toxin clinics: Using Dysport® to enable PIFU
6 Minutes
Dr Clive Bezzina discusses his experience of how Dysport® enabled his service to use a PIFU model.
DYS-UK-008732
A practical guide to implementing a flexible PIFU model
22 minutes
How the implementation of a Patient-Initiatied Follow-Up (PIFU) model may be a practical solution to capacity challenges and help achieve efficiency savings within BoNT-A services.
DYS-UK-008737
Making sense of the changing NHS and funding flows
12 minutes
Dr Judy Willits discusses how the NHS payment scheme has evolved and what the changes could mean for your botulinum toxin services.
DYS-UK-008730
Flexibility with Dysport in Clinical Practice: A case study (53M with Focal Spasticity)
8 minutes
Presented by: Dr Ganesh Bavikatte
DYS-UK-008721
Demystifying the Clinical Relevance of BoNT Immunogenicity
5 minutes
Learn about the difference between neutralising and non-neutralising antibodies, and factors to consider when investigating non-response to BoNT treatment
Presented by: Dr Tim Harrower
DYS-UK-008723
Dysport® in clinical practice: A case study of a 23-year-old male with focal spasticity
9 minutes
Dr Clive Bezzina explains his approach to treating a 23-year-old male with focal spasticity with Dysport®.
DYS-UK-008734
Dysport® in clinical practice: A case study of a 75-year-old female with focal spasticity
5 minutes
Dr Clive Bezzina explains his approach to treating a 75-year-old female with focal spasticity with Dysport®.
DYS-UK-008736
BoNT Immunogenicity: The difference between neutralising and non-neutralising antibodies
3 minutes
Understand the difference between neutralising and non-neutralising antibodies and how this difference should be considered during clinical decision-making.
DYS-UK-008783
Ultrasound Essentials – Introduction
9 minutes
How to use ultrasound to identify muscles in the upper and lower limb, to assist the administration of Dysport® via intramuscular injection.
DYS-UK-008729
Ultrasound Essentials – Shoulder
15 minutes
How to identify muscles of the shoulder using ultrasound for injection with Dysport®.
DYS-UK-008728
Ultrasound Essentials – Elbow
12 minutes
How to identify the elbow flexor and extensor muscles using ultrasound for injection with Dysport®.
DYS-UK-008725
Ultrasound Essentials – Forearm
10 mintues
How to identify the forearm flexor and pronator muscles using ultrasound for injection with Dysport®.
DYS-UK-008726
Ultrasound Essentials – Hand
12 minutes
How to identify the muscles of the thumb and hand using ultrasound for injection with Dysport®.
DYS-UK-008727
Ultrasound Essentials – Lower Limb
18 minutes
How to identify the muscles of the posterior lower leg and foot using ultrasound for injection with Dysport®.
DYS-UK-008731
Concepts and Practical use of GAS (Goal Attainment Scale)
37 minutes
Presented by: Dr Jorge Jacinto
DYS-UK-008465
Functional Anatomy of Adult Spasticity – Part 1
1 hour 30 minutes
Spasticity patterns and anatomy of the upper arm, and the use of ultrasound for injection with Dysport®.
DYS-UK-008554
Functional Anatomy of Adult Spasticity – Part 2
1 hour 30 minutes
Spasticity patterns and anatomy of the upper arm, and the use of ultrasound for injection with Dysport®.
DYS-UK-008468
Dysport® Mechanism of Action
3 minutes
DYS-UK-008722
© IPSEN Ltd, 5th Floor The Point, 37 North Wharf Road, London, W2 1AF, United Kingdom. All rights reserved. August 2024 DYS-UK-008821
